Introduction {#s0005}
============

Birth amounts to a significant oxidative stress to the newborn, given the marked increase in tissue oxygen exposure. Of all organs, the lungs are subjected to the greatest increase in oxygen exposure. As a consequence, a physiologic increase in the production of reactive oxygen species (ROS) by the electron transport chain is expected [@bib1]. Mammalian newborns benefit from the physiological role of ROS for organ development by positively influencing protein functionality through reversible protein oxidation, involving cell signaling and intracellular redox regulation. However, an excessive and abrupt burst of ROS may induce oxidative damage to proteins, lipids, carbohydrates or DNA. This can cause disruption of thiol redox circuits, leading to aberrant cell signaling and dysfunctional redox control, altogether referred to as oxidative stress [@bib2].

Birth associated oxidative stress is tolerated by the newborn because of the activation of the antioxidant defense system (ADS), a process that begins with gestation through the neonatal period [@bib3; @bib4; @bib5; @bib6; @bib7]. Accordingly, an increased oxygen tension in organs which come into direct contact with enviromental oxygen or in active oxygen-consuming organs like the lung or brain respectively, induces the expression of antioxidant and other redox regulation enzymes such as thioredoxin (TRX), thioredoxin reductase (TXNRD) or peroxiredoxin I (PRX I) [@bib6; @bib7; @bib8; @bib9; @bib10]. Many of these enzymes are transcriptionally induced by Nuclear factor (erythroid-derived 2)-like 2 (NRF2), the primary cellular defense against the cytotoxic effects of oxidative stress activated by redox fluctuations and ROS accumulation [@bib11].

Little is known about the factors accounting for the fetal tolerance to lower oxygen delivery, as compared with postnatal life. Yet, it is known that maintenance of a low arterial oxygen tension postnatally in infants with congenital cyanotic heart conditions is compatible with life. Improved outcome of premature infants allowed to reach an adequate blood oxygenation over a longer than traditional period of immediate postnatal life suggests that there might be a biological advantage to a gradual oxygen transition from fetal to neonatal life [@bib12].

In a piglet model of hypoxia/re-oxygenation, urinary biomarkers of oxidative damage to proteins and DNA directly correlate with the inspiratory fraction of oxygen (FiO~2~) used during reoxygenation [@bib13]. Oxygen supplementation in different animal models has proved to be not only toxic to the lung, but also to other organs such as heart, brain or liver. On the contrary, resuscitation in piglet and mice models using FiO~2~ as low as 15--18% improved outcomes [@bib14].

In newborn infants the use of high oxygen concentrations for resuscitation causes a pro-oxidant status and hyperoxemia. Remarkably, a significant correlation was found between oxidized glutathione (GSSG), partial pressure of oxygen (*p*~*a*~O~2)~ and glutathione redox cycle enzymes\' activity [@bib15; @bib16]. Preterm babies not needing resuscitation at birth remained relatively hypoxic in the first minutes of life without short or long-term sequelae [@bib12]. Moreover, preterm infants receiving lower oxygen load after birth exhibited less oxidative stress and developed less bronchopulmonary dysplasia (BPD) [@bib17]. Seemingly, 21% or even lower oxygen concentrations appear to be beneficial for newborn infants because they attenuate oxidative stress associated with reoxygenation after hypoxia. In well-adapted preterm infants, a transitional period of relative hypoxemia seems to be beneficial for postnatal adaptation [@bib1].

Therefore, we hypothesized that delaying the postnatal increase in arterial oxygenation for several hours after birth would reduce short-and-long-term tissue oxidative stress.

To test this hypothesis, we allocated wild-type mice to be delivered either on room-air or in a hypoxic environment, resulting in arterial oxygen tension comparable to fetal values. Lung and brain tissue were chosen for analysis, since the former is exposed to higher enviromental oxygen concentrations and the latter is representative of a vital organ oxygen-supplied by the blood. Reduced (GSH) and oxidized (GSSG) glutathione were measured as indicators of tissue oxidative state, together with its precursors L-cysteine (CySH) and γ-glutamyl cysteine (γ-GC). Expression of relevant redox-sensitive genes such as glutathione reductase (*gsr*), glucose 6 phosphate dehydrogenase (*g6pdx*), phosphogluconate dehydrogenase (*pgd*), malic enzyme 1 (*me1*), NAD(P)H:quinone oxidoreductase 1 (*nqo1*), sulfiredoxin 1(*srxn1*), thioredoxin reductase 1 (*txnrd1*), glutathione peroxidase 1 (*gpx1*) and glutamyl cysteine Ligase Modifier Subunit (*gclm*) were also evaluated.

Material and methods {#s0010}
====================

Chemicals and reagents {#s0015}
----------------------

All chemicals and reagents for analytical determinations were obtained from Sigma Aldrich (St. Louis, USA) with the exception of deuterated phenylalanine (phenylalanine-d5) and methionine (methionine-D3), which were obtained from Cambridge Isotope Laboratories (MA, USA). Materials and reagents for gene expression assays employed were RNeasy mini kit (Qiagen, Hilden, Germany) and GeneAmp Gold RNA PCR Reagent kit, TaqMan^®^ Gene Expression Assay and TaqMan^®^ Gene Expression Master Mix (Applied Biosystems, Life Technologies Corporation, CA, USA).

Animals {#s0020}
-------

All procedures were conducted according to criteria established by the Canadian Council on Animal Care and approved by the Animal Care Committee of The Hospital for Sick Children Research Institutes (Toronto, Canada).

Wild-type C57Bl/6 timed-pregnant mice and newborn pups mice were utilized. Animals were fed food and water *ad*-*libitum* and exposed to regular dark/light cycles of 12/12 h. Half the pups of each litter were sacrificed by decapitation for organ removal at 24 h (P1) of age and the rest at 1 week of life (P7). Lung and brain tissue for biochemical and RNA measurements were rapidly cleared of blood and snap-frozen in liquid nitrogen. The number of animals utilized for each experiment is reported in the figure legends.

Experimental hypoxia exposure model {#s0025}
-----------------------------------

At G18 (8--12 h prior to delivery) pregnant mice from the experimental group were placed in the computer-controlled oxygen concentration chamber (Oxycycler Chambers, Biospherix, Lacona, NY, USA) and maintained at FiO~2~=14%. Animals were closely monitored for signs of delivery. 6--8 h after pups were born, the chamber FiO~2~ was increased to 21%. A control group was similarly placed in the chamber at an equal time point, but maintained in room air. The dam and litter were otherwise handled accordingly, as to the animal care facility protocol. The pups were evaluated either at P1 or P7 and kept in an Oxycycler in regular cages on room air until 1 week post-partum.

Investigators evaluated postnatal adaptation of mouse pups by observing respiratory and motor activity immediately after birth (P1) and breast feeding activity thereafter, in those pups that were allowed to survive until P7.

Determination of low molecular weight thiols {#s0030}
--------------------------------------------

GSH, GSSG, CySH and γ-GC were determined at the Analytical Unit of the Health Research Institute Hospital La Fe (IIS La Fe, Valencia, Spain) by Liquid Chromatography coupled with tandem mass spectrometry (LC--MS/MS) following the Harwood et al. procedure modified based on the Nishiyama\'s thiols determination [@bib18; @bib19]. 10 mM N-ethylmaleimide (NEM) dissolved in PBS 4:1 (v/w) was added to the lung and brain tissue and homogenized for 1 min. Samples were deproteinized with 4% v/v perchloric acid (PCA) and centrifuged at 11,000 rpm for 15 min at 4 °C. 5 μL of a standard solution of phenylalanine-D~5~ and methionine-D~3~ (3.5 µM) was added to 100 μL of supernatant and subjected to LC--MS/MS analysis using a 2795 Alliance coupled to a QuattroMicro (Waters, Manchester, UK). Chromatographic separations were carried out at 50 °C using a C8 Zorbax column (150×2.1 mm^2^, 3.5 µm, Agilent) and injection volume of 5 µL. A 14 min gradient elution was performed at a flow rate of 300 µL min^−1^. Initial conditions A (water, 0.1% v/v formic acid (HCOOH)) 100%: B (acetonitrile, 0.1% v/v HCOOH) (99:1) were kept for 2.5 min, followed by a linear gradient up to 85% B in 2.5 min, and then up to 99% B in 4.5 min. Then, isocratic condition was held for 1.5 min. Finally, a 0.5 min linear gradient was used to return to the initial conditions. Positive ion electrospray MS/MS was recorded using the following conditions: capillary voltage 3.1 kV (kV), desolvation temperature 300 °C and cone and nebulization gases were set at 750 and 50 L/h, respectively. Linear calibration curves in the 20 µM to 2.5 nM concentration range were obtained using peak area values and either phenylalanine-D~5~ (171.1\>125.1, RT=1.8 min) or methionine-D~3~ as internal standards. The limits of detection and quantitation for GSH, GSSG, γ-GC and CySH were in the 5--10 nM range. Due to the relatively high concentration of GSH, samples were appropriately diluted (1:50) in mobile phase and re-analyzed for GS--NEM quantification. MS/MS ionization, fragmentation and retention conditions for each considered analyte are summarized in [Table 1](#t0005){ref-type="table"}.

RNA extraction and cDNA synthesis {#s0035}
---------------------------------

Total RNA was isolated using a *RNeasy mini kit* (Qiagen, Hilden, Germany) following the manufacturer\'s protocol. RNA concentration was quantified by spectrophotometry at 260 nm. Then RNA was reverse transcribed to cDNA using the *GeneAmp Gold RNA PCR Reagent kit* (Applied Biosystems, Carlsbad, CA, USA) following manufacturer\'s instructions. All samples were treated (reverse transcribed and PCR amplified) simultaneously to avoid batch-to-batch bias.

Real-time PCR {#s0040}
-------------

The expression of redox sensitive genes was evaluated by real-time PCR using a commercial thermal-cycler (Applied Biosystems ViiA™ 7 Real-Time PCR System; Life Technologies Corporation, Carlsbad, CA, USA) using TaqMan^®^ gene expression assays and the TaqMan^®^ 2× PCR Master Mix (Applied Biosystems, Life Technologies Corporation, Carlsbad, CA, USA). A list of analyzed genes and TaqMan probes is presented in [Table 2](#t0010){ref-type="table"}. The glyceraldehyde 3-phosphate dehydrogenase (*gapdh*) gene was used as housekeeping gene.

Real time PCR was performed with one cycle of 2 min at 50 °C, required for optimal UNG activity, tailed by one cycle of denaturation of 10 min at 95°C, followed by 40 cycles of 15 s denaturation at 95 °C and 60 s annealing at 60 °C.

Data analysis {#s0045}
-------------

To assess relative abundance of different genes in the lung and brain, the mRNA fold change expression was calculated by the 2(^−ΔΔCt^) method, where Ct is the threshold cycle of each sample, using *gapdh* as the reference gene and the group of 1 day old mice pups born under normoxia, as calibrator [@bib20].

Statistical analysis {#s0050}
--------------------

Statistical analysis of both metabolites and gene data was performed using the Wilkoxon rank sum test for equal medians employing the Statistics Toolbox running in MATLAB R2001b (Mathworks; Natick, MA, USA). The Wilkoxon rank sum test is a two-sided test of the hypothesis where two independent samples come from distributions with equal medians. Differences were considered to be significant at *p*\<0.05.

Results {#s0055}
=======

Postnatal adaptation {#s0060}
--------------------

Mice pups adapted well to the hypoxic atmosphere (FiO~2~=14%) immediately after birth. Respiratory activity and movement was not dissimilar to that of the control group. Pups that were allowed to survive exhibited a normal motor and breastfeeding activity. Hence, no differences in behavior or physical adaptation were noted between the experimental and control groups.

GSH and GSSG levels and GSH/GSSG ratio in lung of newborn mice {#s0065}
--------------------------------------------------------------

We determined GSH and GSSG levels and calculated the GSH/GSSG ratio as a reliable marker of general redox status in lungs of P1 and P7 experimental and control pups.

Lung GSH/GSSG ratios were significantly higher in the experimental group, as compared with values from control animals at 24 h of age (P1) and this difference was still present on time-points ([Fig. 1](#f0005){ref-type="fig"}A) on day 7 of life (P7). The observed higher GSH/GSSG ratio at P1 in the experimental group, as compared with control animals, was mostly due to higher GSH levels ([Fig. 1](#f0005){ref-type="fig"}B). However, at P7, the group differences in the GSH/GSSG ratios reflected lower levels of GSSG in the experimental group ([Fig. 1](#f0005){ref-type="fig"}C).

CySH and γ-GC levels in lungs of newborn mice {#s0070}
---------------------------------------------

The main rate limiting step upon GSH synthesis is the activity of γ-glutamyl-cysteine ligase (GCL) followed by the availability of CySH [@bib21]. We analyzed lung levels of CySH and γ-GC substrate and product of GCL, respectively. Lower levels for γ-GC at P1 were found in the lung for the experimental group. No significant change for lung CySH levels in either group was found (see [Table 3](#t0015){ref-type="table"}).

GSH and GSSG levels and GSH/GSSG ratio in brains of newborn mice {#s0075}
----------------------------------------------------------------

GSH and GSSG were determined and the GSH/GSSG ratio calculated in brains of experimental and control mice pups at P1 and P7 ([Fig. 2](#f0010){ref-type="fig"}A).

In contrast to the lung, no group differences on GSH, GSSG and their ratio were observed at P1 in the brain ([Fig. 2](#f0010){ref-type="fig"}B). Yet, at 7 days of age, the experimental animals showed evidence of reduced brain tissue oxidative stress manifested by a significantly lower GSSG content and increased GSH/GSSG ([Fig. 2](#f0010){ref-type="fig"}C).

CySH and γ-GC levels in brains of newborn mice {#s0080}
----------------------------------------------

No significant differences among CySH and γ-GC levels between both groups were found at P1 in brain tissue. However, low γ-GC levels were found at P7 in the experimental group as compared to those found in the control group (see [Table 3](#t0015){ref-type="table"}).

Redox-sensitive gene expression in lungs of newborn mice {#s0085}
--------------------------------------------------------

The redox potential represented by the GSH/GSSG ratio was significantly increased at P1 and P7 in mice pups\' lungs born in a hypoxic atmosphere (FiO~2~=14%). In addition to metabolic studies, the expression of several genes involved in antioxidant activity and maintenance of redox couples (i.e., GSH/GSSG, NADPH/NADP, and cysteine/cystine) was determined. Hence, mRNA expression of antioxidant genes including *gpx1*, *gclm*, *nqo1* and others in the upper scaffolds of the redox network such as *gsr*, *trxnd1* and *srnx1*, as well as genes involved in NADPH recycling such as *me1*, *g6pdx* and *pgd*, were analyzed.

A significant increase in the mRNA levels of *gpx1*, *srnx1* and *nqo1* in the experimental group was found at P1, compared to the control group ([Fig. 3](#f0015){ref-type="fig"}). However, no significant differences in the expression of these three genes were detected at P7 ([Fig. 3](#f0015){ref-type="fig"}). Conversely, no significant statistical differences in mRNA levels for the rest of the genes were found between control and experimental groups at P1 nor P7 (see [Table 4](#t0020){ref-type="table"}).

Redox-sensitive gene expression in brains of newborn mice {#s0090}
---------------------------------------------------------

Expression for the same genes as reported for the lung was determined in the brain. At P1 *gpx1* levels were significantly higher in the experimental group compared to the control group. Besides, significantly lower expression for *gsr* was found at P7 in the experimental group ([Fig. 4](#f0020){ref-type="fig"}).

By contrast, no significant change in the mRNA expression in the rest of the analyzed genes at P1 or P7 was found (see [Table 5](#t0025){ref-type="table"}).

Discussion {#s0095}
==========

The present study shows that oxidative stress in lung and brain tissue is increased in mice born in room air compared to mice born in a hypoxic environment resembling *in utero* oxygenation conditions. The consequences of enviromental oxygen difference upon tissue oxidative status, confirms that newborns are subjected to oxidative stress during physiologic fetal-to-neonatal transition and postnatal air breathing. It also suggests that delaying exposure to air after birth may reduce birth-associated oxidative stress.

Postnatal adaptation to atmospheric respiration requires rapid changes in lung, airways and cardiopulmonary circulation [@bib1]. Normal-term newborn infants need around 5 min and well-adapted preterm infants need 10 or more minutes to achieve a stable arterial oxygen saturation (SpO~2~) and heart rate. Seemingly, the time needed for postnatal stabilization inversely correlates with gestational age [@bib12]. Interestingly, the use of supplemental oxygen for resuscitation has been associated with increased levels of oxidative stress biomarkers and higher mortality and morbidity such as BPD [@bib17; @bib22].

In experiments performed in isolated hepatocytes of Whistar rats, fetal to neonatal transition was associated with a 15--20-fold decrease in the GSH/GSSG ratio, mainly caused by a GSSG accumulation [@bib23]. We hypothesized that delaying exposure to 21% oxygen after birth keeping an *in utero-*like oxygenation (14%) would reduce the generation of reactive oxygen species, oxidative stress and favor postnatal adaptation. To prove this hypothesis, we studied metabolic adaptation of mice pups delivered in a hypoxic atmosphere (14%) and performed the transition to environmental oxygen (21%) 6--8 h after birth. Notably, we found that the GSH/GSSG ratio was preserved in the lung on the first day after birth and in the lung and brain 1 week thereafter in the experimental group. GSH/GSSG is the most relevant sulfide/di-sulfide couple responsible for cellular redox status, and therefore relevant to regulation of differentiation, division, apoptosis and necrosis [@bib24]. The reduced cellular environment in the lung during postnatal adaptation cannot be explained by increased *de novo* synthesis of GSH, and therefore high levels may indicate a reduction in its metabolic utilization. Accordingly, we did not find differences in the concentration of CySH in the lungs of hypoxic and control groups. Furthermore, concentration of γ-GC was lower in the hypoxic group than in the control group in lungs on day 1 after birth (P1), which may be explained by a feed-back inhibition of glutamyl-cysteine ligase (GCL); the rate-limiting enzyme for the GSH synthesis, by GSH [@bib25]. One week after birth (P7), γ-GC levels in the brain were also diminished in the hypoxic group, suggesting lower GCL activity due to a further reduced environment. Our findings suggest that keeping a period of relative hypoxia after birth stimulates the presence of a suitable redox environment, both in the lung and brain in mice pups at birth and 1 week thereafter. Accordingly, hypoxic newborn piglets were satisfactorily resuscitated and brain activity adequately recovered using 15--18% oxygen. Seemingly, adjusting oxygen supply to the minimal requirements to the brain after an intense hypoxic episode allows an adequate hypoxanthine clearance and recovery of electroencephalographic activity [@bib26]. To the contrary, the use of high FiO~2~ causes oxidative stress and substantial damage to the lung and brain in different animal models [@bib14].

To seek a mechanistic explanation for hypoxic-derived redox protection in our experimental model, we studied NRF2-dependent gene expression both in the lung and brain. NRF2 is considered the first line of defense against oxidative injury and it is responsible for the expression of numerous antioxidant enzymes. We found up-regulation of *nqo1* and *srnx1*and *gpx1* in lung tissue and *gpx*1 in brain tissue of the hypoxic group, during postnatal adaptation under hypoxic conditions. NQO1 antioxidant capacity derives from its ability to divert quinone electrophiles from reactions that could lead to sulfhydryl depletion and in addition, is capable of detoxifying superoxide anion (O~2~^−^) [@bib27; @bib28; @bib29]. *Srnx1* is another antioxidant gene induced by NRF2. SRNX1 catalyzes reactivation of the 2-Cys-peroxyredoxins (Prxs) subfamily (Prx I-IV) after their over-oxidation during ROS detoxification. Prxs rely on a cysteine residue at the active site to reduce hydrogen peroxide (H~2~O~2~), alkyl-hydroperoxide (ROOH) or peroxynitrite (ONOO^−^) [@bib30]. Srnx1 may not only reduce hyperoxidation of the active-site cysteine from sulfinic (Cys--SO~2~H) to sulfenic (Cys--SOH) acid, but it may also play a part in the specific de-glutathionylation of Prxs [@bib31]. Furthermore, gpx1, a relevant antioxidant gene, was up-regulated in the lungs as well as in the brains of mice pups born under hypoxia at P1. The main GPX biological function, akin to that of PRXs, is to reduce lipid hydroperoxides to their corresponding alcohols and reduce free hydrogen peroxide to water, using GSH as cofactor and forming GSSG. GPX activity is couple to the GSR activity, which reduces GSSG to GSH; what is known as the GSH redox cycle [@bib32]. Brain *gsr* expression is reduced in the hypoxic group at P7, reinforcing the idea that the redox environment was more suitable at P7 in the hypoxic group.

Our results show that keeping mice pups in a hypoxic environment (FiO~2~=14%) for 6--8 h after birth, favored a reducing state in both lung and brain immediately after birth, but also 1 week thereafter, suggesting that the experimental intervention also induced a long-lasting redox effect.

Obviously, there are limitations to this study; rodents have evolved to being highly resistant to oxygen-derived free radicals and therefore, it is difficult to assess if such a brief period of mild hypoxia as experienced in our study has preconditioned mice pups to better resist a highly stressful situation such as a hyperoxic stress, which we plan to investigate in forthcoming experiments [@bib33]. Our aim was to reproduce the clinical situation experienced in the delivery room where present guidelines recommend keeping preterm babies within a low oxygen saturation range during the first minutes of life without oxygen supplementation and especially to evaluate how this approach affects the oxidant status in two vital organs, such as the lung and brain [@bib34].

In summary, postnatal redox adaptation of normal-term mice born in a low oxygen atmosphere (14%) and kept for several hours after birth has been studied. An increased GSH/GSSG ratio in lungs and brains of the hypoxic pups was discovered. This reducing state was generated as a consequence of GSH sparing in the immediate postnatal period and decreased production of GSSG 1 week after birth. From a translational point of view, these results strengthen the idea that delaying the oxygenation switch from *in utero* to *ex utero* conditions after birth apparently promotes a reducing state that could be protective to the lung and brain. Babies who did not need postnatal interventions in the delivery room and pointedly preterm infants achieved a stable arterial oxygen saturation (\>90%) 10 or more minutes after birth [@bib12]. In preterm infants endowed with an immature antioxidant defense system, resuscitation maneuvers to rapidly increase postnatal oxygenation could be deleterious and should be carefully applied [@bib1; @bib3; @bib7; @bib8]. Further research should be performed in this regard.
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![Reduced and oxidized glutathione levels at P1 and P7 in lungs of mice pups born under hypoxic conditions (O14; FiO~2~=14%; *n*=6) or under normoxic conditions (O21; FiO~2~=21%; *n*=7). Panel A shows the reduced (GSH) to oxidized (GSSG) glutathione ratio (GSH/GSSG). Panel B represents reduced glutathione (GSH) levels. Panel C shows oxidized glutathione (GSSG) levels. Analytical determinations were performed using ultra-high performance liquid chromatography coupled to mass spectrometry (LC--MS/MS). Comparisons between groups were made using the Wilcoxon rank sum test. Statistical differences are expressed: ^⁎⁎^*p*\<0.01 vs. O21 at P1; ^⁎^*p*\<0.05 vs. O21 group at P1; and \#\# *p*\<0.01 vs. O21 group at P7.](gr1){#f0005}

![Reduced and oxidized glutathione levels at P1 and P7 in the brains of mice pups born under hypoxic conditions (O14; FiO~2~=14%; *n*=7) or under normoxic conditions (O21; FiO~2~=21%; *n*=7). Panel A shows the reduced (GSH) to oxidized (GSSG) glutathione ratio (GSH/GSSG). Panel B shows reduced glutathione (GSH) levels. Panel C shows oxidized glutathione (GSSG) levels. Analytical determinations were performed using ultra-high performance liquid chromatography coupled to mass spectrometry (LC--MS/MS). Comparisons between groups were made using the Wilcoxon rank sum test. Statistical differences are expressed are: ^⁎^*p*\<0.05 vs. O21 group at P1; and \#\# *p*\<0.01 vs. O21 group at P7.](gr2){#f0010}

![RT-PCR expression of genes related to redox regulation in lung tissue at P1 and P7 in mice pups born under hypoxic conditions (O14; FiO~2~=4%; *n*=3) or under normoxic conditions (O21; FiO~2~=21%; *n*=4). Panel A shows fold expression of glutathione peroxidase 1 (*gpx1*). Panel B shows fold expression of sulfiredoxin 1 (*srnx1*). Panel C shows fold expression for NAD(P)H:quinone oxidoreductase 1 (*nqo1*). Comparisons between groups were made using the Wilcoxon rank sum test Statistical differences are expressed as: ^⁎⁎^*p*\<0.01 vs. O21 group at P1. Glyceraldehyde 3-phosphate dehydrogenase (*gapdh*) was used as housekeeping gene.](gr3){#f0015}

![RT-PCR expression of genes related to redox regulation in lung tissue at P1 and P7 in mice pups born under hypoxic conditions (O14; FiO~2~=14%; *n*=3) or under normoxic conditions (O21; FiO~2~=21%; *n*=4). Panel A shows fold expression of malic enzyme 1 (*me1*). Panel B shows fold expression of glutathione reductase (*gsr*). Panel C shows fold expression of interleukin 6. Comparisons between groups were made using the Wilcoxon rank sum test. Statistical differences are expressed as: \# *p*\<0.05 vs. O21 group at P7. Glyceraldehyde 3-phosphate dehydrogenase (*gapdh*) was used as housekeeping gene.](gr4){#f0020}

###### 

Main parameters for MS data acquisition.

  Analyte            Cone (V)   Collision (eV)   Transitions *m*/*z*   Internal standard   Retention time (min)
  ------------------ ---------- ---------------- --------------------- ------------------- ----------------------
  GS--NEM            20         22               433.4\>201.3          Phe--Ala-D5         9.5
  GSSG               20         22               613.2\>355.2          Methionine-D3       5.85
  CyS--NEM           25         20               247.3\>158.2          Phe--Ala-D5         8.84
  γ-GC--NEM          20         25               376\>230.3            Phe--Ala-D5         9.53
  Methionine-D3      20         22               153.2\>63.8           n.a.                3.88
  Phenylalanine-D5   20         15               171.1\>125.1          n.a.                9.07

GS--NEM, CyS--NEM and γ-GC--NEM means N-ethylmaleimide (NEM) covalently bonded through a thioester linkage to reduced glutathione (GSH), Cysteine (CySH) and gamma-glutamylcysteine (γ-GC) respectively.

###### 

TaqMan^®^ gene expression assays (Applied Biosystems, Life Technologies Corporation, Carlsbad, CA, USA) for several Nrf2 target genes and for glyceraldehyde-3-phosphate dehydrogenase (*gapdh*) studied in lungs and brains of mice pups.

  **Gene name**                              **Gene symbol**   **Applied Biosystems TaqMan**^**®**^**gene expression assays**
  ------------------------------------------ ----------------- ----------------------------------------------------------------
  Glutathione reductase                      *gsr*             Mm00439154_m1
  Glucose 6 phosphate dehydrogenase          *g6pdx*, *g6pd*   Mm00656735_g1
  Phosphogluconate dehydrogenase             *pgd*             Mm00503037_m1
  Malic enzyme 1                             *me1*             Mm00782380_s1
  NAD(P)H:quinone oxidoreductase 1           *nqo1*            Mm01253561_m1
  Sulfiredoxin 1                             *srxn1*           Mm00769566_m1
  Thioredoxin reductase 1                    *txnrd1*          Mm00443675_m1
  Glutathione peroxidase 1                   *gpx1*            Mm00656767_g1
  Glutamylcysteine ligase modifier subunit   *gclm*            Mm00514996_m1
  Glyceraldehyde-3-phosphate dehydrogenase   *gapdh*           Mm99999915_g1

###### 

Gamma-glutamylcysteine (γ-GC) and L-cysteine (CySH) levels at P1 and P7 in lungs and brains of mice pups born under hypoxic conditions (O14; FiO~2~=14%; *n*=6) or under normoxic conditions (O21; FiO~2~=21%; *n*=7). Analytical determinations were performed using ultra-high performance liquid chromatography coupled to mass spectrometry (LC--MS/MS). Comparisons between groups were made using Wilcoxon rank sum test.

  Tissue (μmol/g)   Lung levels   Brain levels                                                    
  ----------------- ------------- -------------- ------------------------------------------------ ------------
  O21_1 day         0.009±0.001   0.24±0.055     0.002±001                                        0.04±0.015
  O14_1 day         0.007±0.001   0.28±0.038     0.002±0.0004                                     0.05±0.011
  O21_7 days        0.011±0.003   0.30±0.075     0.004±0.001                                      0.05±0.016
  O14_7 days        0.011±0.001   0.27±0.041     0.003±0.0004[⁎⁎](#tbl3fn){ref-type="table-fn"}   0.05±0.015

*p*\<0.01 vs. O21 at P1.

###### 

RT-PCR expression of genes related to redox regulation in lung tissue at P1 and P7 in mice pups born under hypoxic conditions (O14; FiO~2~=14%; *n*=3) or under normoxic conditions (O21; FiO~2~=21%; *n*=4). The table shows fold expression of Glucose 6 phosphate dehydrogenase (*g6pdx)*, phosphogluconate dehydrogenase (*pgd*), malic enzyme 1 (*me1*), glutathione reductase (*gsr*) and thioredoxin reductase 1 (*txnrd1*). Comparisons between groups were made using the Wilcoxon rank sum test. Glyceraldehyde 3-phosphate dehydrogenase (*gapdh*) gene was used as housekeeping gene.

  Fold change   *g6pdx*     *pgd*       *me1*       *gsr*       *txnrd1*
  ------------- ----------- ----------- ----------- ----------- -----------
  O21_1 day     1.02±0.24   1.01±0.17   1.41±0.34   1.22±0.25   1.05±0.38
  O14_1 day     0.94±0.14   1.47±0.12   1.01±0.11   1.17±0.15   0.54±0.16
  O21_7 days    1.20±0.24   1.65±0.35   1.37±0.34   1.14±0.30   1.04±0.37
  O14_7 days    0.65±0.13   0.95±0.20   1.54±0.46   1.09±0.25   0.72±0.47

^⁎⁎^*p*\<0.01 vs. O21 group at P1.

###### 

RT-PCR expression of genes related to redox regulation in brain tissue at P1 and P7 in mice pups born under hypoxic conditions (O14; FiO~2~=14%; *n*=3) or under normoxic conditions (O21; FiO~2~=21%; *n*=4). The table shows fold expression of Glucose 6 phosphate dehydrogenase (*g6pdx*), phosphogluconate dehydrogenase (*pgd*), malic enzyme 1 (*me1*), glutathione reductase (*gsr*), thioredoxin reductase 1 (*txnrd1*), NADPH:quinone oxidoreductase 1 (*nqo1*) and sulfiredoxin 1(*srxn1*). Comparisons between groups were made using the Wilcoxon rank sum test. Glyceraldehyde 3-phosphate dehydrogenase (*gapdh*) was used as housekeeping gene.

  Fold change   *g6pdx*     *pgd*       *me1*       *gsr*           *txnrd1*    *nqo1*      *srxn1*
  ------------- ----------- ----------- ----------- --------------- ----------- ----------- -----------
  O21_1 day     1.04±0.35   1.02±0.23   1.01±0.17   1.02±0.24       1.02±0.25   1.03±0.29   1.04±0.33
  O14_1 day     1.03±0.29   1.30±0.63   0.99±0.38   1.01±0.47       0.92±0.39   0.86±0.53   0.89±0.34
  O21_7 days    0.60±0.14   0.75±0.28   0.57±0.18   0.64±0.11       0.55±0.11   0.44±0.14   1.95±0.31
  O14_7 days    0.52±0.15   0.73±0.24   0.88±0.15   0.42±0.03^\#^   0.68±0.49   0.49±0.22   1.79±0.37

^\#^*p*\<0.05.

^\*\*^*p*\<0.01 vs. O21 group at P1.
